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Introduction 
Non-pigmented rapidly growing mycobacteria 
(RGM) are non-tuberculous mycobacteria (NTM) 
capable of producing disease in humans. Rapidly 
growing mycobacterium species are ubiquitous in 
nature and are found in soil samples and municipal 
tap water in a worldwide geographic distribution, 
including the United States [1]. 
Nontuberculous mycobacteria may cause delayed 
skin and soft tissue infections after common skin 
procedures or trauma [1-3]. The first case of 
cutaneous NTM inoculation as a complication from 
tattooing was described in 2003 [4]. Since this 
observation, NTM including M. abscessus, M. 
fortuitum, M. haemophilum, M. immunogen, M. 
massiliese, and most commonly M. chelonae have 
been implicated in tattoo-associated skin infection 
[2, 5-8]. We describe a case of tattoo-associated NTM 
skin infection by a novel species of RGM, M. 
mageritense. 
 
Case Synopsis 
A 48-year-old man with no significant past medical 
history presented to our clinic with a two-week 
history of a papulopustular eruption on the shaded 
areas of a tattoo that was placed five-weeks prior in 
the Philippines. He reported that the rash was 
initially pruritic, but at presentation the lesions were 
painful and irritated by clothing. Hydrocortisone 1% 
cream prior to dermatologic evaluation had been of 
no benefit. 
The patient was well appearing and afebrile at the 
time of presentation. Physical examination revealed 
a Fitzpatrick type IV man with monomorphous 
erythematous papules and pustules coalescing into 
plaques along the entire left arm (Figure 1A, B). The 
main outline of the tattoo was spared, with the 
plaques almost exclusively involving the shaded 
portions of ink. No lymphadenopathy was 
appreciated. 
Abstract 
Non-pigmented rapidly growing mycobacteria are 
nontuberculous mycobacteria (NTM) capable of 
producing disease. We report a case of tattoo-
associated NTM infection with a novel species: 
Mycobacterium mageritense. A 48-year-old man 
presented with a two-week history of a papulopustular 
eruption on the shaded areas of a tattoo that had been 
placed five weeks prior while in the Philippines. 
Histopathology from punch biopsies revealed 
suppurative granulomatous dermatitis with acid fast 
bacilli present. Subsequent matrix assisted laser 
desorption/ionization time of flight (MALDI-TOF) mass 
spectrometer identified the bacteria as Mycobacterium 
margeritense. After consultation with infectious disease 
specialists and culture susceptibilities, the patient was 
treated with three months of dual antibiotic therapy 
with minocycline and moxifloxacin. The patient 
experienced a slow but complete resolution of clinical 
skin findings after the course of treatment. Since 
discovery in 1997, M. mageritense infection has been 
demonstrated in a wide spectrum of disease, 
predominantly skin and soft tissue infections. The 
species has not been previously implicated in tattoo-
associated NTM infections. M. mageritense should be 
considered as a specific type of mycobacteria in the 
differential diagnosis for tattoo-associated NTM 
infections owing to differences in antibiotic 
susceptibilities compared to other NTM species. 
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Two punch biopsies were obtained from the left arm 
for histopathology (Figure 2) and culture. Owing to 
high clinical suspicion for mycobacterial infection 
the patient was empirically placed on minocycline 
100mg twice daily. Acid-fast bacteria smear was 
negative and cultures were positive within 3-4 days 
and initially reported as gram negative rods. After 
discussion with a microbiology consultant and 
assistance of a matrix assisted laser 
desorption/ionization time of flight (MALDI-TOF) 
mass spectrometer, the bacteria was quickly and 
accurately identified as Mycobacterium mageritense. 
Subsequently the histopathology revealed suppurative 
granulomatous dermatitis with acid fast bacilli present 
and the Fite-Foraco stain highlighted a cluster of 
bacilli confirming the diagnosis (Figure 3). 
Organisms were not identified on the Ziehl-Neelsen 
stain and Grocott methenamine silver and periodic 
acid-Schiff stains were negative for fungal elements. 
The mycobacterium was sent for susceptibility 
testing and found to be sensitive to minocycline and 
moxifloxacin. 
Our patient was diagnosed with a tattoo-associated 
M. mageritense cutaneous infection. After 
consultation with an infectious disease consultant 
the addition of moxifloxacin 400mg orally once daily 
was added to the minocycline regimen. Dual 
antibiotic therapy was continued for three months 
and the patient had slow but complete resolution of 
clinical skin findings after the completion of 
treatment. 
 
Case Discussion 
Tattoos have become increasingly more common in 
western countries. It is estimated that 24% of adults 
aged 18 to 50 in the United States have tattoos [9]. 
Yet, despite their rise in popularity, a recent survey of 
university students demonstrated a paucity of 
knowledge concerning the complications of tattoos 
[10]. 
Although many skin disorders have been linked to 
tattoos, the most common complication is infection. 
Superficial and deep skin infections with 
Streptococcus pyogenes and Staphylococcus aureus as 
well as inoculation with HIV, hepatitis B, hepatitis C, 
Treponema pallidum, and Clostridium tetani have all 
been described and linked to unsterile instruments 
[11, 12]. 
Figure 1. Erythematous plaques studded with pustules located 
predominantly in the shaded portions of ink A) on the medial left 
arm, and B) posterior left forearm sparing the main outline of the 
tattoo. 
Figure 2. Subcorneal pustule with pseudoepetheliomatous 
hyperplasia and surrounding chronic inflammatory infiltrate. 
H&E 4×.
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Within the past fifteen years, NTM have been 
identified as a source of local cutaneous infections 
leading to tattoo complications [2, 5-8]. NTM 
infections commonly present as painful or pruritic 
erythematous papules, pustules, ulcers, or plaques. 
The average time of onset is usually within four to six 
weeks after tattooing, but has been observed as late 
as six months after inoculation [5, 6]. Contamination 
of equipment or dilution of ink with unsterile tap 
water have been identified as the etiology for most 
tattoo-associated NTM infections [2, 5-8]. However, 
contamination of ink at the manufacturing level has 
also been implicated in outbreaks in the United 
States and Europe [5, 7]. Mycobacterium chelonae is 
the most common species of NTM isolated from 
tattoos, but M. abscessus, M. fortuitum, M. 
haemophilum, M. immunogen, and M. massiliese have 
also been reported. Mycobacterium mageritense has 
never been implicated. 
Mycobacterium mageritense is a rapidly growing NTM 
first discovered in 1997 [13]. The species was named 
in homage to Magerite, the old Arabic word for 
Madrid, where a majority of the initial isolates were 
obtained. Phenotypically, M. mageritense is most 
closely related to M. fortuitum in antibiotic 
susceptibility and biochemical testing [1, 13]. The 
species was originally isolated from sputum samples 
but was initially not considered clinically significant. 
Mycobacterium mageritense has now been shown to 
cause disease in both immunocompetent and 
immunocompromised hosts [14]. This NTM exhibits 
a wide spectrum of disease, predominantly skin and 
post-operative or traumatic soft tissue infections as 
well as osteomyelitis, non-tuberculoid lung 
infections, prosthetic endocarditis, sinusitis, and 
central line associated blood stream infections [3, 15-
19]. 
Previously described cutaneous and surgical site 
wound infections have been suppurative in nature 
and include abscesses and furunculosis [3, 15, 19]. 
Clinical manifestations after suspected inoculation 
may appear within one week [20], but onset of 
symptoms have been reported as late as 100 days [3]. 
Our patient’s presentation of coalescing 
erythematous papules is similar to previous  
descriptions of tattoo-associated NTM infections in 
morphology and onset of symptoms. However, 
despite the similarities, the treatment for M. 
mageritense can differ from other tattoo-associated 
NTM infections. 
No standard guidelines exist for the treatment of 
cutaneous NTM infections. Macrolides, tetracyclines, 
fluoroquinolones, aminoglycosides, cephalosporins, 
rifampin, and linezolid of varying duration have all 
been utilized for treatment [2, 6, 21]. Clarithromycin 
is commonly included in combination therapy for 
treatment of tattoo-associated NTM infections from 
M. abscessus, M. fortuitum, and M. chelonae [2, 6, 21]. 
Isolates of M. mageritense have been shown to be 
largely resistant to macrolides owing to erm gene 
inducible macrolide resistance [14, 21]. Isolates from 
the United States have shown poor susceptibility to 
amikacin and doxycycline and thus M. mageritense is 
often more difficult to treat [14]. Mycobacterium 
mageritense is generally susceptible to 
trimethoprim-sulfamethoxazole, fluoroquinolones, 
and imipenem. Combination therapy for a treatment 
duration of three to twelve months has been shown 
to provide clinical resolution of symptoms [14-20]. 
Despite historical sensitivities, antibiotic therapy 
should be guided by in vitro sensitivities of culture 
isolates. Our patient showed positive response to 
minocycline and moxifloxacin combination therapy 
and cleared his lesions after three months of 
treatment. 
 
Conclusion 
Nontuberculous mycobacterium infections are a 
known, but rare complication of tattooing. 
Inoculation occurs through use of contaminated ink 
and equipment at the tattoo parlors but has also 
been reported during the manufacturing process [2, 
5-8]. To our knowledge, tattoo-associated infection 
by M. mageritense has never been described. 
Mycobacterium mageritense should be specifically 
included in the differential diagnosis for suspected 
tattoo-associated NTM infections owing to the 
differences in antibiotic susceptibilities when 
compared to other NTM species. 
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